Board Decisions

GF/B44/EDP23

Approved by the Board on: 13 April 2021


Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation

The Board:

  1. Approves the funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of GF/B44/ER15 (“Table 1”);
  2. Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;
  3. Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and
  4. Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.